Drug Profile
Research programme: histone deacetylase inhibitors - TopoTarget
Alternative Names: HDAC inhibitors - TopoTargetLatest Information Update: 28 Mar 2011
Price :
$50
*
At a glance
- Originator TopoTarget
- Class Small molecules
- Mechanism of Action Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Huntington's disease; Malaria; Psoriasis
Most Recent Events
- 28 Nov 2003 Preclinical trials in Cancer in Denmark (unspecified route)